1. Chakraborty S, Baruah R, Mishra N, Varma AK (2023). In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins. Genomics and Informatics.21(3):e30.

2. Pandya RK, Jijo A, Cheredath A, Uppangala S, Salian SR, Lakshmi VR, Kumar P, Kalthur G, Gupta S, Adiga SK (2023). Differential sperm histone retention in normozoospermic ejaculates of infertile men negatively affects sperm functional competence and embryo quality. Andrology.

Thesis
1. Pranay Dey. 2023. Imaging molecular interaction dynamics in drug resistance breast cancer. (LIFE09201704001) (Guide: Dr. Abhijit De)

2. Neelima. 2023. Characterization of long non-coding RNAs in human breast cancer. (LIFE09201604008) (Guide: Dr. Amit Dutt)

3. Bhasker D. 2023. Characterizing genome-wide aberrations that underlie oral cancer. (LIFE09201604004) (Guide: Dr. Amit Dutt)

The DICE (Database of Immune Cell Expression, Expression quantitative trait loci (eQTLs) and Epigenomics) aims to understand the role of common genetic variations in human disease.

Bahlis NJ, Costello CL, Raje NS, Levy MY, Dholaria B, Solh M, Tomasson MH, Damore MA, Jiang S, Basu C, Skoura A, Chan EM, Trudel S, Jakubowiak A, Gasparetto C, Chu MP, Dalovisio A, Sebag M, Lesokhin AM (2023). Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nature Medicine.

In 2012, Smart-seq, a method to generate high-coverage transcriptomes from single cells, was used to analyse the full-length messenger-RNA transcriptomes of circulating tumour cells from a patient with melanoma.

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)